| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/10/2004 | WO2003084472A3 Recombinant p. falciparum merozoite protein-142 vaccine |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003080855A3 Deracemisation of amines |
| 06/10/2004 | WO2003079995A3 Neisseria mutants, lipooligosaccharides and immunogenic compositions |
| 06/10/2004 | WO2003070970A3 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 06/10/2004 | WO2003068917A3 Functionalization of carotenoid compounds |
| 06/10/2004 | WO2003067215A3 Automatic threshold setting and baseline determination for real-time pcr |
| 06/10/2004 | WO2003066842A3 Method for producing recombinant proteins in micro-organisms |
| 06/10/2004 | WO2003064626A3 Double-stranded oligonucleotides |
| 06/10/2004 | WO2003062433A3 Element for the s-phase and meristem specific expression of genes in plants and use thereof |
| 06/10/2004 | WO2003060128A3 Compositions, methods and systems for discovery of lipopeptides |
| 06/10/2004 | WO2003060120A3 Means for identifying neisseiria menengitidis specific genes |
| 06/10/2004 | WO2003054755A3 Vaccine for periodontal disease |
| 06/10/2004 | WO2003054188A3 Seminal vesicle tissue-specific promoters and uses thereof |
| 06/10/2004 | WO2003054142A3 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/10/2004 | WO2003048318A3 Methods for the identification of genetic features |
| 06/10/2004 | WO2003040170A9 Antibodies to cd40 |
| 06/10/2004 | WO2003039346A9 Diagnostics and therapeutics for ocular abnormalities |
| 06/10/2004 | WO2003037258A3 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 06/10/2004 | WO2003026689A8 Autologous growth factor cocktail composition, method of production and use |
| 06/10/2004 | WO2003016483A3 METHOD OF LABELLING cRNAs FOR PROBING OLIGO-BASED MICROARRAYS |
| 06/10/2004 | WO2003015711A3 Combination motif immune stimulatory oligonucleotides with improved activity |
| 06/10/2004 | WO2003012082A3 Method for modulating stem cell differentiation using stem loop rna |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2003002606A3 Nucleic acids encoding ion channels |
| 06/10/2004 | WO2002094877A3 New nuclear receptor cofactors and related modulators |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | WO2002057293B1 Modified zinc finger binding proteins |
| 06/10/2004 | WO2002040629A3 Promoters exhibiting endothelial cell specificity and methods of using same |
| 06/10/2004 | US20040111769 Sugar beet genes involved in stress tolerance |
| 06/10/2004 | US20040111768 Transcription factor stress-related proteins and methods of use in plants |
| 06/10/2004 | US20040111767 for maintaining homeostasis by sense or antisense expression of chimeric gene; genetic engineering |
| 06/10/2004 | US20040111766 for use as therapeutic agent or additive for ingestible food/feed |
| 06/10/2004 | US20040111765 Production of urokinase in plant-based expression systems |
| 06/10/2004 | US20040111764 expression cassette comprising promoter operably linked to a polynucleotide encoding a recombinational DNA repair polypeptide |
| 06/10/2004 | US20040111763 for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits |
| 06/10/2004 | US20040111762 by genetically modifying a lipid metabolic pathway of a plant; for vegetable/edible oil or chemical materials |
| 06/10/2004 | US20040111761 Sunflower anti-pathogenic proteins and genes and their uses |
| 06/10/2004 | US20040111760 Production of stilbenes in transgenic plants and the method of producing thereof |
| 06/10/2004 | US20040111758 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 06/10/2004 | US20040111674 Graphical viewer for biomolecular sequence data |
| 06/10/2004 | US20040110941 by cloning, amplifying and expressing DNA sequences using polymerase chain reaction; for therapy, diagnosis or catalysis; solid phase synthesis |
| 06/10/2004 | US20040110935 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 06/10/2004 | US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 06/10/2004 | US20040110932 Comprises polypeptide agent of Class I cytokine receptor subfamily for prevention and treatment cell proliferation disorders; antitumor agents |
| 06/10/2004 | US20040110928 Peptide conjugates for drug delivery |
| 06/10/2004 | US20040110926 Comprises nucleotide sequences coding interleukin receptor associated kinase-2 (IRAK-2) for diagnosis and treatment of infections; solid tumors; leukemias; alzheimer's and autoimmune disorders |
| 06/10/2004 | US20040110924 Identification and characterization of multiple splice variants of the kappa3-related opioid receptor (KOR-3) gene |
| 06/10/2004 | US20040110920 Novel g protein-coupled receptor protein and dna thereof |
| 06/10/2004 | US20040110919 Comprises toxic jellyfish protein for use as pesticide |
| 06/10/2004 | US20040110727 Administering inhibitor of aldehyde detoxifying agent, such as buthionine sulphoximine or crotonaldehyde to treat cancer; hydrolysis by esterase |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110714 Stabilized naked DNA compositions |
| 06/10/2004 | US20040110713 Molecular hybridization; gene expression inhibition; treating Scott syndrome and bleeding disorders |
| 06/10/2004 | US20040110708 Binary hybrid mutational vectors |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110705 Antisense oligonucleotides targeted to nucleic acids encoding Talin, a cytoplasmic protein; gene expression inhibition |
| 06/10/2004 | US20040110703 Gene expression inhibition; molecular hybridization; drug screening, medical diagnosis |
| 06/10/2004 | US20040110702 Nucleotide hybridizes with nucleic acid encoding MAGE-D1(melanoma antigen); gene expression inhibition |
| 06/10/2004 | US20040110701 Molecular hybridization; nervous system disorder treatment; drug screening, medical diagnosis |
| 06/10/2004 | US20040110700 Nucleotide hybridizes with nucleic acid molecule encoding CD1D and inhibits gene expression; genetic engineering; drug screening |
| 06/10/2004 | US20040110699 Modulation of ABCC2 expression |
| 06/10/2004 | US20040110698 Oligonucleotides and methods using same for treating cox-ll associated diseases |
| 06/10/2004 | US20040110697 Nucleic acid injected into hapatic vein lumen and delivered to primate liver |
| 06/10/2004 | US20040110683 Cell proliferation factor Fwa267 |
| 06/10/2004 | US20040110682 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110675 Mutant human factor ix with an increased resistance to inhibition by heparin |
| 06/10/2004 | US20040110674 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 06/10/2004 | US20040110670 Heterologous expression of neisserial proteins |
| 06/10/2004 | US20040110668 Nucleic acid sequences differentially expressed in cancer tissue |
| 06/10/2004 | US20040110297 Method of transffering selected molecules |
| 06/10/2004 | US20040110296 biological conjugates used for drug delivery; side effect reduction |
| 06/10/2004 | US20040110295 Plasmid that codes heterologous nucleotide sequences and is capable of expressing recombinant polypeptides eukaryotic cells; gene transfer tools |
| 06/10/2004 | US20040110294 Use of mutagenic dna polymerase for producing random mutations |
| 06/10/2004 | US20040110293 Sequence specific DNA recombination in eukaryotic cells |
| 06/10/2004 | US20040110292 Method for the production of nuclear transfer embryos |
| 06/10/2004 | US20040110291 Modulation of adipophilin expression |
| 06/10/2004 | US20040110282 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 06/10/2004 | US20040110281 Vector and a method for expression and selection of random peptide sequences |
| 06/10/2004 | US20040110269 Protection against mycobacterial infections |
| 06/10/2004 | US20040110268 Attenuated Pasteurellaceae virulence genes are identified and used to screen bactericides and produce vaccines which prevent infection |
| 06/10/2004 | US20040110262 Recombinant L-N-carbamoylase from Arthrobacter aurescens and method of producing L-amino acids therewith |
| 06/10/2004 | US20040110260 Recombinant minimal catalytic vanadium haloperoxidases and their uses |
| 06/10/2004 | US20040110258 Biodegradation, reduce the nitrogen concentration of fossil fuels, cleaving C N bonds of carbazole, using Sphingomonas, Pseudomonas, Rhodococcus having operon gene, encoding amidase for conversion of carbazole to 2-aminobiphenyl-2,3-diol |
| 06/10/2004 | US20040110257 Production of farnesol and geranylgeraniol |
| 06/10/2004 | US20040110255 purposes of affinity purification or detection; increased or decreased resistance to denaturation |
| 06/10/2004 | US20040110254 Method for producing alpha-1, 6-branched alph-1, 4-glucans from sucrose |
| 06/10/2004 | US20040110253 used in studying T cells and their antigenic targets in autoimmunity, hypersensitivity, and cancer; for drug screening; genetic engineering |
| 06/10/2004 | US20040110252 Yeast-based assay |
| 06/10/2004 | US20040110251 enterohemorrhagic Escherichia coli (EHEC); used to prevent contamination of a large batch of foodstuffs; solid phase synthesis; kits |
| 06/10/2004 | US20040110250 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 06/10/2004 | US20040110236 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 06/10/2004 | US20040110235 for the treatment of diabetes and other diseases using systematic evolution of ligands by exponential enrichment (SELEX) |
| 06/10/2004 | US20040110232 Novel cark protein and nucleic acid molecules and uses therefor |
| 06/10/2004 | US20040110225 Fluorescent proteins from aquatic species |
| 06/10/2004 | US20040110224 Segment synthesis |
| 06/10/2004 | US20040110222 Biopolymer detecting method and biochip |
| 06/10/2004 | US20040110220 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 06/10/2004 | US20040110219 Detecting amount of nucleic acid encoding UKW polypeptide through hybridization and comparing with a predetermined standard value |